US Stock MarketDetailed Quotes

Xeris Pharmaceuticals (XERS)

Watchlist
  • 6.710
  • +0.210+3.23%
Close Jun 10 15:59 ET
  • 6.541
  • -0.169-2.52%
Post 19:57 ET
1.16BMarket Cap91.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xeris Pharmaceuticals (XERS) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Recorlev49.77M59.87%
Gvoke20.8M25.02%
Keveyis11.89M14.30%
Royalty, contract and other revenue673K0.81%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States291.85M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.23%
Sample Name
Sample Code
 +1.31%
Sample Name
Sample Code
 -1.03%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-2.32%
5
ProShares UltraShort Energy
DUG
-2.99%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +2.95%
Sample Name
Sample Code
 +1.98%
Sample Name
Sample Code
 +1.29%
4
Tencent Music
TME
+0.77%
5
Zai Lab
ZLAB
+0.52%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East continue to escalate. After Iran shot down a U.S. Apache helicopter, the U.S. military launched retaliatory airs Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -